• 1
    Murphy TF. Haemophilus infections. In: BraunwaldF, KasparD, HauserS, LongoD, JamesonL, eds. Harrison's principles of internal medicine. New York: McGraw Hill, 2001:93942.
  • 2
    Bandi V, Apicella MA, Mason E et al. Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med 2001; 164:211419.
  • 3
    Hill AT, Campbell EJ, Hill SL, Bayley DL, Stockley RA. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med 2000; 109:28895.
  • 4
    Patel IS, Seemungal TA, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002; 57:75964.
  • 5
    Rosell A, Monso E, Soler N et al. Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease. Arch Intern Med 2005; 165:8917.
  • 6
    Angrill J, Agusti C, De Celis R et al. Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors. Thorax 2002; 57:1519.
  • 7
    Roberts DE, Cole P. Use of selective media in bacteriological investigation of patients with chronic suppurative respiratory infection. Lancet 1980; 1:7967.
  • 8
    Bandi V, Jakubowycz M, Kinyon C et al. Infectious exacerbations of chronic obstructive pulmonary disease associated with respiratory viruses and non-typeable Haemophilus influenzae. FEMS Immunol Med Microbiol 2003; 37:6975.
  • 9
    Groenewegen KH, Wouters EF. Bacterial infections in patients requiring admission for an acute exacerbation of COPD; a 1-year prospective study. Respir Med 2003; 97:7707.
  • 10
    Clemans DL, Bauer RJ, Hanson JA et al. Induction of proinflammatory cytokines from human respiratory epithelial cells after stimulation by nontypeable Haemophilus influenzae. Infect Immun 2000; 68:443040.
  • 11
    Moller LV, Timens W, Van Der Bij W et al. Haemophilus influenzae in lung explants of patients with end-stage pulmonary disease. Am J Respir Crit Care Med 1998; 157:9506.
  • 12
    Erwin AL, Smith AL. Nontypeable Haemophilus influenzae: understanding virulence and commensal behavior. Trends Microbiol 2007; 15:35562.
  • 13
    Foxwell AR, Kyd JM, Cripps AW. Nontypeable Haemophilus influenzae: pathogenesis and prevention. Microbiol Mol Biol Rev 1998; 62:294308.
  • 14
    St Geme JW III. Insights into the mechanism of respiratory tract colonization by nontypable Haemophilus influenzae. Pediatr Infect Dis J 1997; 16:9315.
  • 15
    Gnehm HE, Pelton SI, Gulati S, Rice PA. Characterization of antigens from nontypable Haemophilus influenzae recognized by human bactericidal antibodies. Role of Haemophilus outer membrane proteins. J Clin Invest 1985; 75:164558.
  • 16
    Musher DM, Hague-Park M, Baughn RE, Wallace RJ Jr, Cowley B. Opsonizing and bactericidal effects of normal human serum on nontypable Haemophilus influenzae. Infect Immun 1983; 39:297304.
  • 17
    McGuinness G, Naidich DP. CT of airways disease and bronchiectasis. Radiol Clin North Am 2002; 40:119.
  • 18
    King PT, Hutchinson PE, Johnson PD, Holmes PW, Freezer NJ, Holdsworth SR. Adaptive immunity to nontypeable Haemophilus influenzae. Am J Respir Crit Care Med 2003; 167:58792.
  • 19
    Barenkamp SJ, Munson RS Jr, Granoff, DM. Subtyping isolates of Haemophilus influenzae type b by outer-membrane protein profiles. J Infect Dis 1981; 143:66876.
  • 20
    Figueira MA, Ram S, Goldstein R, Hood DW, Moxon ER, Pelton SI. Role of complement in defense of the middle ear revealed by restoring the virulence of nontypeable Haemophilus influenzae siaB mutants. Infect Immun 2007; 75:32533.
  • 21
    Leijh PC, Van Den Barselaar MT, Dubbeldeman-Rempt I, Van Furth R. Kinetics of intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes. Eur J Immunol 1980; 10:7507.
  • 22
    Leijh PC, Van Den Barselaar MT, Van Zwet TL, Daha MR, Van Furth R. Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes. J Clin Invest 1979; 63:77284.
  • 23
    Groeneveld K, Eijk PP, Van Alphen L, Jansen HM, Zanen HC. Haemophilus influenzae infections in patients with chronic obstructive pulmonary disease despite specific antibodies in serum and sputum. Am Rev Respir Dis 1990; 141:131621.
  • 24
    Hansen MV, Musher DM, Baughn RE. Outer membrane proteins of nontypable Haemophilus influenzae and reactivity of paired sera from infected patients with their homologous isolates. Infect Immun 1985; 47:8436.
  • 25
    Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 1991; 4:35995.
  • 26
    Joiner KA, Schmetz MA, Sanders ME et al. Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9. Proc Natl Acad Sci USA 1985; 82:480812.
  • 27
    Winkelstein JA, Moxon ER. The role of complement in the host's defense against Haemophilus influenzae. J Infect Dis 1992; 165 (Suppl. 1):S6265.
  • 28
    Steele NP, Munson RS Jr, Granoff DM, Cummins JE, Levine RP. Antibody-dependent alternative pathway killing of Haemophilus influenzae type b. Infect Immun 1984; 44:4528.
  • 29
    Weiser JN, Pan N, McGowan KL, Musher D, Martin A, Richards J. Phosphorylcholine on the lipopolysaccharide of Haemophilus influenzae contributes to persistence in the respiratory tract and sensitivity to serum killing mediated by C-reactive protein. J Exp Med 1998; 187:63140.
  • 30
    Neary JM, Yi K, Karalus RJ, Murphy TF. Antibodies to loop6 of the P2 porin protein of nontypeable Haemophilus influenzae are bactericidal against multiple strains. Infect Immun 2001; 69:7738.
  • 31
    Ahren IL, Williams DL, Rice PJ, Forsgren A, Riesbeck K. The importance of a beta-glucan receptor in the nonopsonic entry of nontypeable Haemophilus influenzae into human monocytic and epithelial cells. J Infect Dis 2001; 184:1508.
  • 32
    Hawkins RE, Malone JD, Ebbeling WL. Common variable hypogammaglobulinemia presenting as nontypable Haemophilus influenzae septic arthritis in an adult. J Rheumatol 1991; 18:7756.
  • 33
    Lindberg K, Gustafson R, Samuelson A, Rynnel-Dagoo B. Impact of IgG replacement therapy and antibiotic treatment on the colonization of non-encapsulated Haemophilus influenzae in the nasopharynx in patients with hypogammaglobulinaemia. Scand J Infect Dis 2001; 33:9048.
  • 34
    Musher DM, Wallace RJ Jr. Bacteremic infections caused by nontypable Haemophilus influenzae in patients with dysgammaglobulinemia. J Clin Microbiol 1983; 17:1435.
  • 35
    Samuelson A, Borrelli S, Gustafson R et al. Characterization of Haemophilus influenzae isolates from the respiratory tract of patients with primary antibody deficiencies: evidence for persistent colonizations. Scand J Infect Dis 1995; 27:30313.
  • 36
    Van der Hilst JC, Smits BW, Van Der Meer JW. Hypogammaglobulinaemia: cumulative experience in 49 patients in a tertiary care institution. Neth J Med 2002; 60:1407.
  • 37
    Pallares DE, Figueroa JE, Densen P, Giclas PC, Marshall GS. Invasive Haemophilus influenzae type b infection in a child with familial deficiency of the beta subunit of the eighth component of complement. J Pediatr 1996; 128:1023.
  • 38
    Williams BJ, Morlin G, Valentine N, Smith AL. Serum resistance in an invasive, nontypeable Haemophilus influenzae strain. Infect Immun 2001; 69:695705.
  • 39
    Peng T, Hao L, Madri JA et al. Role of C5 in the development of airway inflammation, airway hyperresponsiveness, and ongoing airway response. J Clin Invest 2005; 115:1590600.
  • 40
    Reynolds HY, Fulmer JD, Kazmierowski JA, Roberts WC, Frank MM, Crystal RG. Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest 1977; 59:16575.
  • 41
    Sethi S, Evans N, Grant BJ, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med 2002; 347:46571.
  • 42
    Sethi S, Wrona C, Eschberger K, Lobbins P, Cai X, Murphy TF. Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 177:4917.
  • 43
    Groeneveld K, Van Alphen L, Eijk PP, Visschers G, Jansen HM, Zanen HC. Endogenous and exogenous reinfections by Haemophilus influenzae in patients with chronic obstructive pulmonary disease: the effect of antibiotic treatment on persistence. J Infect Dis 1990; 161:51217.
  • 44
    Murphy TF, Brauer AL, Schiffmacher AT, Sethi S. Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170:26672.
  • 45
    Ahren IL, Janson H, Forsgren A, Riesbeck K. Protein d expression promotes the adherence and internalization of non-typeable Haemophilus influenzae into human monocytic cells. Microb Pathog 2001; 31:1518.
  • 46
    Craig JE, Cliffe A, Garnett K, High NJ. Survival of nontypeable Haemophilus influenzae in macrophages. FEMS Microbiol Lett 2001; 203:5561.
  • 47
    Forsgren J, Samuelson A, Ahlin A, Jonasson J, Rynnel-Dagoo B, Lindberg A. Haemophilus influenzae resides and multiplies intracellularly in human adenoid tissue as demonstrated by in situ hybridization and bacterial viability assay. Infect Immun 1994; 62:6739.
  • 48
    St Geme JW 3rd, Falkow S. Haemophilus influenzae adheres to and enters cultured human epithelial cells. Infect Immun 1990; 58:403644.
  • 49
    Swords WE, Ketterer MR, Shao J, Campbell CA, Weiser JN, Apicella MA. Binding of the non-typeable Haemophilus influenzae lipooligosaccharide to the PAF receptor initiates host cell signalling. Cell Microbiol 2001; 3:52536.
  • 50
    Van Schilfgaarde M, Van Alphen L, Eijk P, Everts V, Dankert J. Paracytosis of Haemophilus influenzae through cell layers of NCI-H292 lung epithelial cells. Infect Immun 1995; 63:472937.
  • 51
    King PT, Ngui J, Farmer M, Hutchinson P, Holmes P, Holdsworth S. Cytotoxic T cell and natural killer cell responses to non-typeable Haemophilus influenzae. Clin Exp Immunol 2008; 152:54251.